Sfoglia per SSD
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 A.L. Catapano, I. Graham, G. De Backer, O. Wiklund, M.J. Chapman, H. Drexel, A.W. Hoes, C.S. Jennings, U. Landmesser, T.R. Pedersen, Z. Reiner, G. Riccardi, M. Taskinen, L. Tokgozoglu, W.M.M. Verschuren, C. Vlachopoulos, D.A. Wood, J.L. Zamorano, L. Badimon, C. Funck-Brentano, S. Agewall, G. Barón-Esquivias, J. Borén, E. Bruckert, A. Cordero, A. Corsini, P. Giannuzzi, F. Gueyffier, G. Krstačić, M. Lettino, C. Lionis, G.Y.H. Lip, P. Marques-Vidal, D. Milicic, J. Pedro-Botet, M.F. Piepoli, A.G. Rigopoulos, F. Ruschitzka, J. Tunón, A. Von Eckardstein, M. Vrablik, T.W. Weiss, B. Williams, S. Windecker, R. Zimlichman
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2017 A.L. Catapano, I. Graham, G. De Backer, O. Wiklund, M.J. Chapman, H. Drexel, A.W. Hoes, C.S. Jennings, U. Landmesser, T.R. Pedersen, Ž. Reiner, G. Riccardi, M. Taskinen, L. Tokgozoglu, W.M. Monique Verschuren, C. Vlachopoulos, D.A. Wood, J. Luis Zamorano, M. Cooney
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias : the Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR)
2016 A.L. Catapano, I. Graham, G. De Backer, O. Wiklund, M..J. Chapman, H. Drexel, A.W. Hoes, C.S. Jennings, U. Landmesser, T.R. Pedersen, Ž. Reiner, G. Riccardi, M. Taskinen, L. Tokgozoglu, W.M.M. Verschuren, C. Vlachopoulos, D.A. Wood, J.L. Zamorano
2016 European Guidelines on cardiovascular disease prevention in clinical practice
2016 M.F. Piepoli, A.W. Hoes, S. Agewall, C. Albus, C. Brotons, A.L. Catapano, M. Cooney, U. Corrà, B. Cosyns, C. Deaton, I. Graham, M.S. Hall, F.D. Richard Hobbs, M. Løchen, H. Löllgen, P. Marques Vidal, J. Perk, E. Prescott, J. Redon, D.J. Richter, N. Sattar, Y. Smulders, M. Tiberi, H. Bart van der Worp, I. van Dis, W.M. Monique Verschuren
2016 European Guidelines on cardiovascular disease prevention in clinical practice
2016 M.F. Piepoli, A.W. Hoes, S. Agewall, C. Albus, C. Brotons, A.L. Catapano, M. Cooney, U. Corrà, B. Cosyns, C. Deaton, I. Graham, M.S. Hall, F..D..R. Hobbs, M. Løchen, H. Löllgen, P. Marques Vidal, J. Perk, E. Prescott, J. Redon, D.J. Richter, N. Sattar, Y. Smulders, M. Tiberi, H..B. Van Der Worp, I. Van Dis, W.M.M. Verschuren, S. Binno, G. De Backer, M. Roffi, V. Aboyans, N. Bachl, S. Carerj, L. Cho, J. Cox, J. De Sutter, G. Egidi, M. Fisher, D. Fitzsimons, O.H. Franco, M. Guenoun, C. Jennings, B. Jug, P. Kirchhof, K. Kotseva, G.Y.H. Lip, F. Mach, G. Mancia, F.M. Bermudo, A. Mezzani, A. Niessner, P. Ponikowski, B. Rauch, A. Stauder, G. Turc, O. Wiklund, S. Windecker, J.L. Zamorano, S. Achenbach, L. Badimon, G. Barón Esquivias, H. Baumgartner, J.J. Bax, V. Dean, Ç. Erol, O. Gaemperli, P. Kolh, P. Lancellotti, P. Nihoyannopoulos, A. Torbicki, A.V. Carneiro, B. Metzler, R. Najafov, V. Stelmashok, C. De Maeyer, M. Dilić, I. Gruev, D. Miličić, H. Vaverkova, I. Gustafsson, I. Attia, D. Duishvili, J. Ferrières, N. Kostova, Z. Klimiashvili, R. Hambrecht, K. Tsioufis, E. Szabados, K. Andersen, C. Vaughan, B. Zafrir, S. Novo, K. Davletov, F. Jashari, A. Kerimkulova, I. Mintale, G. Saade, Z. Petrulioniene, C. Delagardelle, C.J. Magri, V. Rudi, L. Oukerraj, B..E. Çölkesen, H. Schirmer, R.P. Dos Reis, D. Gherasim, S. Nedogoda, M. Zavatta, V. Giga, S. Filipova, L.R. Padial, A. Kiessling, A. Mahdhaoui, D. Ural, E. Nesukay, C. Gale
2016 European Guidelines on cardiovascular disease prevention in clinical practice the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
2016 M.F. Piepoli, A.W. Hoes, S. Agewall, C. Albus, C. Brotons, A.L. Catapano, M. Cooney, U. Corra, B. Cosyns, C. Deaton, I. Graham, M.S. Hall, F.D. Richard Hobbs, M. Løchen, H. Lollgen, P. Marques Vidal, J. Perk, E. Prescott, J. Redon, D.J. Richter, N. Sattar, Y. Smulders, M. Tiberi, H. Bart Van Der Worp, I. Van Dis, W.M. Monique Verschuren, G. De Backer, M. Roffi, V. Aboyans, N. Bachl, H. Bueno, S. Carerj, L. Cho, J. Cox, J. De Sutter, G. Egidi, M. Fisher, D. Fitzsimons, O.H. Franco, M. Guenoun, C. Jennings, B. Jug, P. Kirchhof, K. Kotseva, G.Y.H. Lip, F. Mach, G. Mancia, F.M. Bermudo, A. Mezzani, A. Niessner, P. Ponikowski, B. Rauch, L. Ryden, A. Stauder, G. Turc, O. Wiklund, S. Windecker, J.L. Zamorano
2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
2016 M.F. Piepoli, A.W. Hoes, S. Agewall, C. Albus, C. Brotons, A.L. Catapano, M. Cooney, U. Corrà, B. Cosyns, C. Deaton, I. Graham, M.S. Hall, F.D..R. Hobbs, M. Løchen, H. Löllgen, P. Marques Vidal, J. Perk, E. Prescott, J. Redon, D.J. Richter, N. Sattar, Y. Smulders, M. Tiberi, H. Bart van der Worp, I. van Dis, W.M.M. Verschuren, M. Piepoli
2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia
2018 U. Landmesser, M.J. Chapman, J.K. Stock, P. Amarenco, J.J.F. Belch, J. Borén, M. Farnier, B.A. Ference, S. Gielen, I. Graham, D.E. Grobbee, G.K. Hovingh, T.F. Lüscher, M.F. Piepoli, K.K. Ray, E.S. Stroes, O. Wiklund, S. Windecker, J.L. Zamorano, F. Pinto, L. Tokgözoǧlu, J.J. Bax, A.L. Catapano
2019 ESC/EAS guidelines for the management of dyslipidaemias : Lipid modification to reduce cardiovascular risk
2019 F. Mach, C. Baigent, A.L. Catapano, K.C. Koskina, M. Casula, L. Badimon, M.J. Chapman, G.G. De Backer, V. Delgado, B.A. Ference, I.M. Graham, A. Halliday, U. Landmesser, B. Mihaylova, T.R. Pedersen, G. Riccardi, D.J. Richter, M.S. Sabatine, M.-. Taskinen, L. Tokgozoglu, O. Wiklund, S. Windecker, V. Aboyans, J.-. Collet, V. Dean, D. Fitzsimons, C.P. Gale, D. Grobbee, S. Halvorsen, G. Hindricks, B. Iung, P. Juni, H.A. Katus, C. Leclercq, M. Lettino, B.S. Lewis, B. Merkely, C. Mueller, S. Petersen, A.S. Petronio, M. Roffi, E. Shlyakhto, I.A. Simpson, M. Sousa-Uva, R.M. Touyz, D. Nibouche, P.H. Zelveian, P. Siostrzonek, R. Najafov, P. van de Borne, B. Pojskic, A. Postadzhiyan, L. Kypris, J. Spinar, M.L. Larsen, H.S. Eldin, M. Viigimaa, T.E. Strandberg, J. Ferrieres, R. Agladze, U. Laufs, L. Rallidis, L. Bajnok, T. Gudjonsson, V. Maher, Y. Henkin, M.M. Gulizia, A. Mussagaliyeva, G. Bajraktari, A. Kerimkulova, G. Latkovskis, O. Hamoui, R. Slapikas, L. Visser, P. Dingli, V. Ivanov, A. Boskovic, M. Nazzi, F. Visseren, I. Mitevska, K. Retterstol, P. Jankowski, R. Fontes-Carvalho, D. Gaita, M. Ezhov, M. Foscoli, V. Giga, D. Pella, Z. Fras, L. Perez de Isla, E. Hagstrom, R. Lehmann, L. Abid, O. Ozdogan, O. Mitchenko, R.S. Patel
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
2020 F. Mach, C. Baigent, A.L. Catapano, K.C. Koskinas, M. Casula, L. Badimon, M.J. Chapman, G.G. De Backer, V. Delgado, B.A. Ference, I.M. Graham, A. Halliday, U. Landmesser, B. Mihaylova, T.R. Pedersen, G. Riccardi, D.J. Richter, M.S. Sabatine, M.-. Taskinen, L. Tokgozoglu, O. Wiklund
27-Hydroxycholesterol modulation of low density lipoprotein metabolism in cultured human hepatic and extrahepatic cells
1993 S. Bellosta, A. Corsini, F. Bernini, A. Granata, G. Didoni, M. Mazzotti, R. Fumagalli
2β-3,4-Unsaturated sialic acid derivatives: Synthesis optimization, and biological evaluation as Newcastle disease virus hemagglutinin-neuraminidase inhibitors
2020 P. La Rocca, P. Rota, M. Piccoli, F. Cirillo, A. Ghiroldi, V. Franco, P. Allevi, L. Anastasia
The 3' untranslated region of human cyclin-dependent kinase 5 regulatory subunit 1 contains regulatory elements affecting transcript stability
2007 S. Moncini, A. Bevilacqua, M. Venturin, C. Fallini, A. Ratti, A. Nicolin, P. Riva
3' UTR (AGG)n repeat of glial cell line-derived neurotrophic factor (GDNF) gene polymorphism in schizophrenia
2004 A. Michelato, C. Bonvicini, M. Ventriglia, C. Scassellati, R. Randazzo, S. Bignotti, R. Beneduce, M.A. Riva, M. Gennarelli
3,4 methylenedioxymethamphetamine (ecstasy) impairs eight-arm radial maze performance and arm entry pattern in rats
2002 D. Braida, M. Pozzi, R. Cavallini, M. Sala
3,4 Methylenedioxymethamphetamine-induced conditioned place preference (CPP) is mediated by endocannabinoid system
2005 D Braida, S Iosue, S Pegorini, M Sala
3-Aryl-N-aminoylsulfonylphenyl-1H-pyrazole-5-carboxamides : a new class of selective Rac inhibitors
2013 N. Ferri, S.K. Bernini, A. Corsini, F. Clerici, E. Erba, S. Stragliotto, A. Contini
3-Hydroxy-3-methylglutaric acid (HMGA) reduces dietary cholesterol induction of saturated bile in hamster
1982 C. Di Padova, E. Bosisio, G. Cighetti, P. Rovagnati, M. Mazzocchi, C. Colombo, R. Tritapepe
3-Methoxytyramine and different neuroleptics: Dissociation from HVA and DOPAC
1978 A. Groppetti, M. Parenti, C.L. Galli, A. Bugatti, F. Cattabeni, A.M. Di Giulio, G. Racagni
3. Symposium of cellular biology of epithelia : atti del convegno (6 novembre 2006)
2008 E.B. Donetti, N. Gagliano, C. Sforza
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile